Bleeding into an emphysematous bulla
Pure erythroid leukaemia with leukaemic cells mimicking myeloma cells
Managing relapsed and refractory Hodgkin lymphoma
The non-haematopoietic biological effects of erythropoietin
Ehlers-Danlos syndrome – a historical review
Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype : a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients
Alternate day pomalidomide retains anti-myeloma effect with reduced adverse events and evidence of in vivo immunomodulation
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma
Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma
Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis
Adverse outcomes of blood transfusion in children : analysis of UK reports to the serious hazards of transfusion scheme 1996–2005
Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation
Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets
Loss of phospholipid membrane asymmetry and sialylated glycoconjugates from erythrocyte surface in haemoglobin E β-thalassaemia
Increased CD177 (PRV1) expression in thalassaemia and the underlying erythropoietic activity
β2-Adrenergic receptor and adenylate cyclase gene polymorphisms affect sickle red cell adhesion
A human anti-D monoclonal antibody selected for enhanced FcγRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies
Ultra low dose thalidomide in elderly patients with myeloma
Severe pancytopenia associated with a minor paroxysmal nocturnal haemoglobinuria clone and response to ciclosporin A in a heavily pretreated multiple myeloma patient
‘Precursors’ of classical Hodgkin lymphoma in samples of angioimmunoblastic T-cell lymphoma
Clinical effectiveness of decitabine in severe sickle cell disease
Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1) : a potential therapeutic modality implication against natural killer/T cell malignancy
UK NEQAS for Blood Coagulation Annual Scientific Meeting